Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Spontaneous intracerebral hemorrhage due to coagulation disorders Quinones-Hinojosa A; Gulati M; Singh V; Lawton MTNeurosurg Focus 2003[Oct]; 15 (4): E3Although intracranial hemorrhage accounts for approximately 10 to 15% of all cases of stroke, it is associated with a high mortality rate. Bleeding disorders account for a small but significant risk factor associated with intracranial hemorrhage. In conditions such as hemophilia and acute leukemia associated with thrombocytopenia, massive intracranial hemorrhage is often the cause of death. The authors present a comprehensive review of both the physiology of hemostasis and the pathophysiology underlying spontaneous ICH due to coagulation disorders. These disorders are divided into acquired conditions, including iatrogenic and neoplastic coagulopathies, and congenital problems, including hemophilia and rarer diseases. The authors also discuss clinical features, diagnosis, and management of intracranial hemorrhage resulting from these bleeding disorders.|Adolescent[MESH]|Adult[MESH]|Aged[MESH]|Blood Coagulation Disorders/*complications/physiopathology[MESH]|Case Management[MESH]|Cerebral Hemorrhage/diagnosis/*etiology/therapy[MESH]|Child[MESH]|Child, Preschool[MESH]|Coagulation Protein Disorders/complications/genetics/physiopathology[MESH]|Craniotomy[MESH]|Female[MESH]|Fibrinolytic Agents/adverse effects[MESH]|Forecasting[MESH]|Hemophilia A/complications[MESH]|Hemostasis/physiology[MESH]|Humans[MESH]|Infant[MESH]|Male[MESH]|Middle Aged[MESH]|Neoplasms/complications[MESH]|Platelet Aggregation Inhibitors/adverse effects[MESH]|Postoperative Complications/blood[MESH]|Pregnancy[MESH]|Pregnancy Complications, Hematologic/blood[MESH]|Puerperal Disorders/blood[MESH]|Randomized Controlled Trials as Topic[MESH]|Risk Factors[MESH] |